Tvardi Therapeutics TVRD Cash Flow Statement (2013-2026)

NASDAQ TVRD
$1.28 -0.05 (-3.76%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Tvardi Therapeutics Quarterly Cash Flow Statement

Periods 54 quarters
Latest Jun 2026

Tvardi Therapeutics reported cash from operations of -$9.20M and free cash flow of -$9.20M for the quarter ended Jun 2026, down 56.8% year over year. This cash flow statement covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.01M-33.38M-27.91M-4.47M-23.84M-31.31M-27.65M-32.34M-28.90M-32.61M-29.67M-6.97M-5.51M-10.67M-4.08M-8.49M-5.53M-7.28M-6.80M-6.46M
Share-based Compensation
4.39M8.78M5.70M4.66M3.57M3.80M3.35M3.44M3.33M3.60M3.35M-3.19M0.08M0.08M0.08M0.63M0.34M0.35M0.37M0.34M
Gains from Sales and Divestitures
Asset Writedowns and Impairment
1.49M4.27M
Cash from Restructuring
0.44M0.78M-0.35M
Cash from Operations
-14.12M-1.25M-25.52M-4.50M-25.19M-23.51M-34.62M-20.45M-19.64M-17.37M-30.45M23.64M-6.66M-4.83M-7.69M-5.87M-4.26M-5.69M-5.90M-9.20M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.08M0.04M0.01M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Change in Working Capital
Change in Inventory
-0.68M1.55M-1.62M0.55M1.13M-0.10M-0.15M-0.45M-0.08M0.39M0.00M0.73M
Change in Accured Expenses
0.32M2.05M0.64M2.83M6.98M-4.78M-6.32M9.25M-2.90M3.24M-10.15M12.73M-1.62M4.61M-2.64M2.78M0.79M0.21M-2.15M
Change in Taxes
Other Working Capital Changes
-0.41M-0.42M-0.42M-0.43M-0.45M-0.46M-0.46M-0.47M-0.34M-0.64M-0.39M-1.19M0.99M0.72M-0.15M-1.26M-0.38M0.96M
Investing Activities
Capital Expenditures
0.04M2.05M0.84M0.21M
Sales of Property, Plant and Equipment
Cash from Investing Activities
14.43M-53.58M33.43M29.68M21.18M44.42M17.71M32.80M23.16M-30.20M25.95M15.29M2.50M5.00M-10.88M-9.55M5.35M5.00M4.98M5.14M
Financing Activities
Other financing activities
Debt Issuance and Repayment
Long-Term Debt Repayments
Current Debt
Change in Capital Stock
Net Equity Issued and Repurchased
0.34M0.32M0.00M0.18M0.10M0.02M0.56M0.56M0.00M0.42M0.11M0.00M
Misc.
Cash from Financing Activities
0.34M45.29M0.00M0.18M0.10M0.02M0.56M1.12M36.48M-0.69M0.69M-0.01M27.01M-1.60M24.63M-0.32M0.00M
Change in Cash
0.66M-9.54M7.91M25.36M-3.91M20.93M-16.35M12.36M4.63M-11.10M-5.19M-1.62M-6.67M22.18M-20.18M9.21M0.77M-0.68M-0.88M-4.09M
Free Cash Flow
-14.12M-1.25M-25.57M-4.50M-25.19M-23.51M-34.62M-20.45M-19.64M-19.42M-31.29M23.43M-6.66M-4.83M-7.69M-5.87M-4.26M-5.69M-5.90M-9.20M
Net Cash Flow
0.66M-9.54M7.91M25.36M-3.91M20.93M-16.35M12.36M4.63M-11.10M-5.19M39.62M-4.17M27.18M-20.18M9.21M0.77M-0.69M-0.92M-4.06M

Tvardi Therapeutics Cash Flow Statement API

Pull Tvardi Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TVRD&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY